Search Result "TG-101348"
Research Article
Novel Compound, ND-17, Regulates the JAK/STAT, PI3K/AKT, and MAPK Pathways and Restrains Human T-lymphoid Leukemia Development
Journal: Current Cancer Drug Targets
Volume: 22 Issue: 5 Year: 2022 Page: 404-413
Author(s):
Research Article
ND-16: A Novel Compound for Inhibiting the Growth of Cutaneous T CellLymphoma by Targeting JAK2
Journal: Current Cancer Drug Targets
Volume: 22 Issue: 4 Year: 2022 Page: 328-339
Author(s):
Small Molecule Inhibitors of NF-κB and JAK/STAT Signal Transduction Pathways as Promising Anti-Inflammatory Therapeutics
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 11 Issue: 1 Year: 2011 Page: 55-78
Author(s): Y. A. Ivanenkov, K. V. Balakin, Y. Lavrovsky
JAK Inhibitors: Pharmacology and Clinical Activity in Chronic Myeloprolipherative Neoplasms
Journal: Current Medicinal Chemistry
Volume: 20 Issue: 9 Year: 2013 Page: 1147-1161
Author(s): J. Trelinski,T. Robak
Apply Filters
Volume Years
Content Type
Ads